FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 維他奶國際集團有限公司 呈交日期： 2025年7月8日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00345 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件 ...

Summary of Key Points Core Viewpoint - On July 7, 34 Hong Kong-listed companies conducted share buybacks, totaling 30.99 million shares and an aggregate amount of HKD 921 million [1][2]. Group 1: Buyback Details - Tencent Holdings repurchased 1.002 million shares for HKD 501 million, with a highest price of HKD 502.000 and a lowest price of HKD 494.400, bringing its total buyback amount for the year to HKD 38.542 billion [1][2]. - AIA Group repurchased 5.5 million shares for HKD 377 million, with a highest price of HKD 69.150 and a lowest price of HKD 68.050, totaling HKD 16.352 billion in buybacks for the year [1][2]. - Founder Holdings repurchased 10.386 million shares for HKD 1.174 million, with a highest price of HKD 1.150 and a lowest price of HKD 1.110, accumulating HKD 3.541 million in buybacks for the year [1][2]. Group 2: Buyback Rankings - The highest buyback amount on July 7 was from Tencent Holdings at HKD 501 million, followed by AIA Group at HKD 377 million [1][2]. - In terms of share quantity, Founder Holdings had the most significant buyback with 10.386 million shares, followed by AIA Group with 5.5 million shares and China Electric Power Technology with 2.26 million shares [1][2].

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 維他奶國際集團有限公司 呈交日期： 2025年7月7日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 FF305 | 1). | 購回股份 (擬註銷但尚未註銷) | | 702,000 | 0.0654 % | HKD | 9.175 | | --- | --- | --- | --- | --- | --- | --- | | | 變動日期 | 2025年3月14日 | | | | | | 2). | 購回股份 (擬註銷但尚未註銷) | | 90,000 | 0.0084 % | HKD | 9.193 | | | 變動日期 | 2025年3月17日 | | | | | | 3). | 購回股份 (擬註銷但尚未註銷) | | 270, ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 維他奶國際集團有限公司 呈交日期： 2025年7月4日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00345 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關 ...

公司名稱： 維他奶國際集團有限公司 呈交日期： 2025年7月3日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00345 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對 其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份 內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 （於香港註冊成立之有限公司） （股份代號：345） 授出購股權及績效股份單位 本公告乃根據香港聯合交易所有限公司證券上市規則（「上市規則」）第 17.06A、17.06B 及 17.06C 條而作出。 維他奶國際集團有限公司（「本公司」，連同其附屬公司（「附屬公司」）， 統稱「本集團」）之董事會（「董事會」）謹此宣佈，於二零二五年六月三十 日（「授出日期」），本公司分別根據於二零二二年八月三十日採納之購股權 計劃（「二零二二年購股權計劃」）及於二零二一年三月二十二日採納之股份 獎勵計劃（「二零二一年股份獎勵計劃」），向若干合資格參與者（統稱「承 授人」）授出購股權（「購股權」）及績效股份單位（「績效股份單位」）， 惟須待承授人接納後，方告作實。 根據二零二二年購股權計劃授出購股權 有關授出購股權的詳情如下： 考慮到(i)向承授人授出購股權乃對其過往表 現之認可，及(ii)已計入購股權之歸屬期，本 公司薪 ...

Core Insights - Vitasoy International Group Limited reported a revenue of HKD 6.274 billion for the fiscal year ending March 31, 2025, representing a 1% year-on-year growth, while profit attributable to equity holders surged by 102% to HKD 235 million [1] - The revenue growth was primarily driven by strong performance in core products in mainland China and robust results in the Hong Kong market [1] - The mainland China market, as the largest market for the group, recorded a revenue of HKD 3.363 billion, with a 1% year-on-year growth excluding exchange rate effects [1] Mainland China Market Performance - The second half of the fiscal year saw a notable improvement in sales performance in mainland China, with a revenue growth of 2%, compared to flat growth in the first half [1] - Operating profit in mainland China reached HKD 311 million, with a 42% year-on-year growth excluding exchange rate effects, attributed to effective sales strategies and improved operational efficiency [1] Hong Kong Market Performance - Vitasoy International's operating profit in the Hong Kong market increased by 24%, achieving an operating profit margin of 12%, driven by higher sales volume, reduced indirect costs, and lower raw material costs [1] Australia and New Zealand Market Recovery - In Australia, the business experienced continuous sales growth and reduced operating losses, with revenue growth of 5% in local currency and a reduction in operating losses by 4% to AUD 15 million [2] - The recovery followed the resolution of earlier production line issues, indicating a rebound in business momentum despite a competitive sales environment [2] Product Development and Market Trends - The company has launched its own sugar-free tea products in response to the growing demand in the sugar-free tea sector, with positive performance in the Hong Kong market [2] - Vitasoy International plans to continue product development and innovation based on consumer needs, aiming to enhance business value through superior taste and quality [2] Future Outlook - For the upcoming fiscal year, Vitasoy International aims to strengthen sales execution, increase sales per outlet, and improve product supply [3] - The company is focused on expanding market share in core product categories like plant-based milk and ready-to-drink tea, particularly in mainland China, while also addressing challenges in growth rates [3] - The group remains confident in its ability to capture growth opportunities through its core product portfolio and health-focused innovations [3]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 維他奶國際集團有限公司 呈交日期： 2025年6月27日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) 00345 | | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | 事件 | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | 每股發行/出售價 (註4) | | | | | 已發行股份（不包括庫 ...

Core Insights - Vitasoy International Group Limited reported a revenue of approximately HKD 6.274 billion for the fiscal year 2024/2025, representing a year-on-year growth of 1% [2] - The company achieved a gross profit of about HKD 3.218 billion, with a year-on-year increase of 3% [2] - The proposed final dividend is HKD 0.102 per share, combined with an interim dividend of HKD 0.04 per share, totaling HKD 0.142 per share for the fiscal year [2] Financial Performance - The net profit attributable to equity holders increased by 102% year-on-year, reaching HKD 235 million [2] - Sales in mainland China showed improvement in the second half of the fiscal year, contributing to a moderate overall sales growth [2] - Operating profit from mainland operations grew by 41% year-on-year, with an operating profit margin of 9% [2] Business Strategy and Market Position - The company aims to expand market share in plant-based milk and ready-to-drink tea products to maintain business scale and profitability amid a slowing beverage market [3] - Vitasoy's Hong Kong operations saw a 24% increase in operating profit, with an operating profit margin of 12%, driven by rising sales and reduced indirect costs [3] - The company has stabilized prices for its lemon tea products in mainland China after a price reduction of 10% to 15% [3] Industry Context - The beverage industry is experiencing overall growth slowdown and intensified competition, which poses challenges for Vitasoy's future growth [4][5] - The company's recent performance relies heavily on cost control and operational efficiency rather than breakthrough innovations or market disruptions [4][5]

Core Insights - Vitasoy International Group Limited reported a revenue of HKD 6.274 billion for the fiscal year 2024/2025, reflecting a 1% year-on-year growth, while profit attributable to equity holders surged by 102% to HKD 235 million [1] - The company aims to enhance sales execution and increase product supply in the new fiscal year [1] Group 1: Financial Performance - Revenue from mainland China reached HKD 3.363 billion, with a 1% year-on-year growth excluding exchange rate effects, and a 2% increase in the second half of the fiscal year [1] - Operating profit in mainland China was HKD 311 million, showing a 42% year-on-year growth excluding exchange rate effects, attributed to improved sales strategies and operational efficiency [1] Group 2: Market Dynamics - In Australia, Vitasoy's business experienced continuous sales growth and reduced operating losses, with a 5% revenue increase in local currency for the Australia and New Zealand segment [2] - The operating loss for the Australia and New Zealand business decreased by 4% to AUD 15 million [2] Group 3: Product Development and Consumer Trends - Vitasoy has launched its own sugar-free tea products in response to the growing demand in the sugar-free tea market, with positive market performance in Hong Kong [2] - The company plans to continue product development and innovation based on consumer needs and expectations, focusing on enhancing the value of its tea beverage offerings [2] Group 4: Pricing Strategy - The company observed a shift in consumer behavior towards price sensitivity, leading to a price reduction in lemon tea in mainland China, which has now stabilized [2] - Vitasoy will not further reduce prices in the mainland market and anticipates short-term challenges due to slowing growth in plant-based milk and ready-to-drink tea categories [2]